Cargando…

New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases

Detalles Bibliográficos
Autores principales:	Assini, Andrea, Benedetti, Luana, Di Maio, Silvia, Schirinzi, Erika, Del Sette, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849645/ https://www.ncbi.nlm.nih.gov/pubmed/32468450 http://dx.doi.org/10.1007/s10072-020-04484-5

Ejemplares similares

Correction to: New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases
por: Assini, Andrea, et al.
Publicado: (2020)

Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy
por: Parodi, Italo Carlo, et al.
Publicado: (2020)

Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital
por: Ottaviani, Donatella, et al.
Publicado: (2020)

COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
por: Martinelli-Boneschi, Filippo, et al.
Publicado: (2022)

Guillain-Barré syndrome associated with COVID-19: an atypical, late-onset presentation
por: Fletman, Elizabeth W., et al.
Publicado: (2021)

HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
por: Gigli, Gian Luigi, et al.
Publicado: (2020)

Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
por: Trimboli, Michele, et al.
Publicado: (2021)

The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation
por: Biassoni, Erica, et al.
Publicado: (2021)

COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications
por: Kajumba, Mayanja M., et al.
Publicado: (2020)

Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases
por: Bouattour, Nadia, et al.
Publicado: (2021)

Guillain–Barré syndrome associated with BNT162b2 COVID vaccination: a first case report from South Korea
por: Kim, Namkyun, et al.
Publicado: (2022)

An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID)
por: Ferrarese, Carlo, et al.
Publicado: (2020)

Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system
por: Fabiani, Massimo, et al.
Publicado: (2021)

Electroencephalography during SARS-CoV-2 outbreak: practical recommendations from the task force of the Italian Society of Neurophysiology (SINC), the Italian League Against Epilepsy (LICE), and the Italian Association of Neurophysiology Technologists (AITN)
por: Grippo, Antonello, et al.
Publicado: (2020)

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
por: Garcia, Jao Jarro, et al.
Publicado: (2021)

Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)
por: Dubbioso, Raffaele, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on Italian Otolaryngology Units: a nationwide study
por: Mannelli, Giuditta, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy
por: Garnero, Martina, et al.
Publicado: (2020)

Effect of lockdown on the management of ischemic stroke: an Italian experience from a COVID hospital
por: Frisullo, Giovanni, et al.
Publicado: (2020)

Long-term neurological manifestations of COVID-19: prevalence and predictive factors
por: Pilotto, Andrea, et al.
Publicado: (2021)

Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
por: Jain, Rajendra Singh, et al.
Publicado: (2014)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
por: Verboon, Christine, et al.
Publicado: (2021)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

Update on cerebrovascular manifestations of COVID-19
por: Naeimi, Reza, et al.
Publicado: (2020)

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19
por: Pourahmad, Ramtin, et al.
Publicado: (2020)

Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of an observational study
por: Bonizzato, Silvia, et al.
Publicado: (2021)

Les immunoglobulines anti-COVID en pédiatrie, pour qui, pourquoi, comment ?
por: Mershati, S. El, et al.
Publicado: (2023)

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Knowledge and training of Italian students in Healthcare Settings on COVID-19 vaccines and vaccination strategies, one year after the immunization campaign
por: BECHINI, ANGELA, et al.
Publicado: (2023)

Neurological manifestations and comorbidity associated with COVID-19: an overview
por: Kumar, Mukesh, et al.
Publicado: (2020)

Fulminant encephalitis as a sole manifestation of COVID-19
por: Etemadifar, Masoud, et al.
Publicado: (2020)

Early neurological manifestations of hospitalized COVID-19 patients
por: Vacchiano, Veria, et al.
Publicado: (2020)

The neurological manifestations of COVID-19: a review article
por: Niazkar, Hamid Reza, et al.
Publicado: (2020)

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience
por: Romozzi, Marina, et al.
Publicado: (2022)

Syndrome de Guillain-Barré et COVID-19 : case report
por: Diaz, P., et al.
Publicado: (2020)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fona3dcenn0mtqvj6f5a6b9ur5